Double-digit organic revenue growth and margin expansion continued, with strong results in India, Poland, and Diagnostics. Leverage improved, synergies from acquisitions realized, and strategic options for the Indian business remain under review.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.